Category: <span>Treatment</span>

Category: Treatment

Cancer Center, mesothelioma, Mesothelioma News, Treatment

2025’s Top Cancer Hospitals: Best Places for Mesothelioma Care

 

People diagnosed with mesothelioma have another reason to trust major hospitals this year. U.S. News & World Report released its 2025-2026 Best Hospitals for Cancer list, ranking the University of Texas MD Anderson Cancer Center in Houston as the top hospital for cancer care in America for the 11th year. Memorial Sloan Kettering Cancer Center […]

The post 2025’s Top Cancer Hospitals: Best Places for Mesothelioma Care appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

asbestos exposure, Clinical Trials/Research/Emerging Treatments, Doctors/Specialists, Immunotherapy, mesothelioma, Mesothelioma News, Treatment

Mayo Clinic Reveals New Test for Mesothelioma

 

Mayo Clinic researchers have created a new blood test to better detect mesothelioma. This could result in earlier diagnoses. It might also lead to new options for targeted therapies. The test finds complex DNA patterns that are common in mesothelioma cells.  This new approach is more accurate than standard mesothelioma blood tests. This may also […]

The post Mayo Clinic Reveals New Test for Mesothelioma appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Chemotherapy/Chemo drugs, Clinical Trials/Research/Emerging Treatments, Immunotherapy, mesothelioma, Mesothelioma News, Treatment

FDA Approves Keytruda With Chemotherapy to Treat Mesothelioma

 

The U.S. Food and Drug Administration has approved a new first-line treatment for people with pleural mesothelioma that can’t be removed with surgery. This new approval is specifically for a Keytruda (pembrolizumab) plus pemetrexed and platinum chemotherapy combination.  The FDA’s approval follows promising results in phases 2 and 3 of the Keynote-483 trial. This clinical […]

The post FDA Approves Keytruda With Chemotherapy to Treat Mesothelioma appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Chemotherapy/Chemo drugs, Clinical Trials/Research/Emerging Treatments, Immunotherapy, mesothelioma, Mesothelioma News, Treatment

FDA Approves Keytruda With Chemotherapy to Treat Mesothelioma

 

The U.S. Food and Drug Administration has approved a new first-line treatment for people with pleural mesothelioma that can’t be removed with surgery. This new approval is specifically for a Keytruda (pembrolizumab) plus pemetrexed and platinum chemotherapy combination.  The FDA’s approval follows promising results in phases 2 and 3 of the Keynote-483 trial. This clinical […]

The post FDA Approves Keytruda With Chemotherapy to Treat Mesothelioma appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Cancer Center, Doctors/Specialists, Mesothelioma News, Treatment

Top Mesothelioma Hospitals Lead Best Cancer Hospitals List

 

U.S. News & World Report has named University of Texas MD Anderson Cancer Center the Best Hospital for Cancer for the tenth year in a row. Memorial Sloan Kettering Cancer Center in New York claimed the second spot on the list. Mayo Clinic in Rochester, Dana-Farber Brigham Cancer Center in Boston and City of Hope […]

The post Top Mesothelioma Hospitals Lead Best Cancer Hospitals List appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Clinical Trials/Research/Emerging Treatments, mesothelioma, Mesothelioma News, Treatment

FDA Prioritizes Keytruda Chemotherapy Mesothelioma Combo

 

In a significant development for mesothelioma patients, the U.S. Food and Drug Administration has accepted priority review for a new supplemental Biologics License Application. The anticipated FDA approval could mark the beginning of a new era in the management of advanced pleural mesothelioma, offering a brighter future for those affected. The review seeks approval for […]

The post FDA Prioritizes Keytruda Chemotherapy Mesothelioma Combo appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Asbestos (general), asbestos exposure, Cancer Center, Doctors/Specialists, Mesothelioma News, Treatment, veterans

VA Benefits Now Available to Millions of Veterans

 

VA health care benefits are now available to millions more veterans in one of the largest expansions of coverage in the U.S. The inclusion of significantly more veterans compared to past bills comes at the direction of President Joe Biden. Veterans Who Now Qualify Benefits cover exposure to asbestos and a variety of other potential […]

The post VA Benefits Now Available to Millions of Veterans appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Cancer Center, Doctors/Specialists, mesothelioma, Mesothelioma News, Treatment

Renowned Thoracic Surgeon Enhances Mesothelioma Care in FL

 

Dr. Rodney Landreneau is joining the renowned Thoracic Surgical Program at Tampa General Hospital. He spent decades caring for patients with pleural mesothelioma and lung cancer patients in Western Pennsylvania at the University of Pittsburgh and Penn Highlands Healthcare. He’s now moved more than 1,000 miles to help augment Tampa General Hospital Cancer Institute’s successful […]

The post Renowned Thoracic Surgeon Enhances Mesothelioma Care in FL appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Clinical Trials/Research/Emerging Treatments, mesothelioma, Mesothelioma News, Treatment

New Drug to Treat Mesothelioma Hailed as a Major Breakthrough

 

ADI-PEG20 or pegargiminase is being hailed as the first drug of its kind to be incorporated successfully with chemotherapy in 20 years. Researchers say this new drug could bring hope to thousands of mesothelioma survivors and their families.  The drug blocks the cancer’s food supply, ensuring the disease can’t spread. It prevents cancer cells from […]

The post New Drug to Treat Mesothelioma Hailed as a Major Breakthrough appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Clinical Trials/Research/Emerging Treatments, mesothelioma, Mesothelioma News, Treatment

FDA Fast Tracks UV1 Vaccine Combo for Mesothelioma

 

The U.S. Food and Drug Administration granted fast-track designation to a new therapeutic cancer vaccine. The approval is for UV1 in combination with the immunotherapy drugs Opdivo (nivolumab) and Yervoy (ipilimumab) to manage malignant pleural mesothelioma that can’t be managed with surgery.  Therapeutic cancer vaccines, unlike preventive vaccines, treat existing cancers. Fast Track expedites the […]

The post FDA Fast Tracks UV1 Vaccine Combo for Mesothelioma appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Clinical Trials/Research/Emerging Treatments, mesothelioma, Mesothelioma News, Treatment

Polaris Submits Application for New Mesothelioma Treatment

 

Multinational biopharmaceutical company Polaris Group announced their application for a rolling submission of a new mesothelioma treatment this month. The Biologic License Application for the experimental drug ADI-PEG 20 is the first step in U.S. Food and Drug Administration approval.  The application outlines the use of ADI-PEG 20 for non-epithelioid mesothelioma alongside treatment with pemetrexed […]

The post Polaris Submits Application for New Mesothelioma Treatment appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Chemotherapy/Chemo drugs, Immunotherapy, mesothelioma, Mesothelioma News, Treatment

Trial Shows Keytruda With Chemotherapy Superior to Chemo Alone

 

Results of a new phase 3 clinical trial published in the Journal of Clinical Oncology indicate that a chemoimmunotherapy regimen combining chemotherapy with immunotherapy drugs improves patient survival more than chemotherapy alone for pleural mesothelioma. Study researchers used pembrolizumab (Keytruda) alongside platinum and pemetrexed chemotherapy. Christina S. Baik, MD, MPH, reviewed the phase 3 trial […]

The post Trial Shows Keytruda With Chemotherapy Superior to Chemo Alone appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

asbestos exposure, Legal, Mesothelioma News, Treatment

Libby Clinic Files for Bankruptcy After Asbestos Claims Ruling

 

The Center for Asbestos Related Disease in Libby, Montana, has filed for Chapter 11 bankruptcy protection. The decision comes after a jury ruled in June that CARD had submitted 337 false asbestos claims, forcing the clinic to pay nearly $6 million in penalties and damages.  BNSF Railway filed the lawsuit against CARD under the federal […]

The post Libby Clinic Files for Bankruptcy After Asbestos Claims Ruling appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Cancer Center, Mesothelioma News, Treatment

Mesothelioma Specialty Centers Lead U.S. News Best Hospitals Rankings

 

U.S. News & World Report has named University of Texas MD Anderson Cancer Center the Best Hospital for Cancer for the ninth year in a row in its annual rankings. The Houston-based hospital is followed by Memorial Sloan Kettering in New York; Mayo Clinic in Rochester, Minnesota; UCLA Medical Center in Los Angeles and Dana-Farber […]

The post Mesothelioma Specialty Centers Lead U.S. News Best Hospitals Rankings appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Clinical Trials/Research/Emerging Treatments, Mesothelioma News, Treatment

Mesothelioma Immunotherapy Receives Orphan Drug Designation

 

A novel therapy for mesothelioma has been given orphan drug designation by the U.S. Food and Drug Administration.  Avenge Bio, a biotechnology company working on a new treatment platform for immunotherapy, announced it was granted the designation for its drug  AVB-001 in June. It is currently enrolling patients in ongoing phase 1 and phase 2 […]

The post Mesothelioma Immunotherapy Receives Orphan Drug Designation appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.